Research Paper on Mitochondrial Targeting for Lung Cancer Therapy

A 2.0 MB DOCX file authored by Mabel Catalán and last updated on 2026-05-04. The document presents research evaluating a combined therapeutic strategy using TPP+-conjugated lipophilic cations and doxycycline to overcome drug resistance in non-small cell lung cancer under hypoxic conditions.

Use Cases

• Analyzing the cytotoxic effects of mitochondrial destabilization compounds based on the described in vitro experiments.
• Studying synergistic drug combinations for cancer therapy based on the results for TPP+C10/doxycycline and GA-TPP+C10/doxycycline.
• Investigating hypoxia-driven metabolic adaptations in cancer cells based on the described experimental conditions.

Strengths

• File size is 2.0 MB, indicating a substantial document.
• License is CC-BY-4.0, allowing for open sharing and reuse.
• The description provides a detailed scientific background and methodology.

Limitations

• Row count is unknown, which may limit suitability assessment.
• Column-level documentation is absent; field semantics must be inferred after download.
• The data is contained in a DOCX file, which may require parsing to extract structured information.

Provenance

Source

figshare

Collection Method

Likely contains experimental results from in vitro studies on lung cancer cell lines.

Time Range

Publication date is not specified; last platform update was 2026-05-04.

Freshness

Last updated 2026-05-04 05:31:57; freshness should be verified.

Geography

Geographic coverage of the research is not specified.